Kinematic-guided BoNT-A Treatment for ET and PD Tremor
Status:
Unknown status
Trial end date:
2020-06-01
Target enrollment:
Participant gender:
Summary
The present study attempts to fill a critical knowledge gap of BoNT A in tremor management by
studying the efficacy of IncobotulinumtoxinA (Xeomin®) injection for hand tremor in essential
tremor and idiopathic Parkinson disease using data regarding composition of tremor obtained
through sophisticated, yet clinically accessible multi-sensor based kinematic information.
Phase:
Phase 2
Details
Lead Sponsor:
Western University, Canada
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA